Cover Image

Taxane-induced morphea in a patient with CREST syndrome

Susan Michele Bouchard, Melinda Mohr, Robert Pariser
  • Melinda Mohr
    Eastern Virginia Medical School, Department of Dermatology, United States
  • Robert Pariser
    Eastern Virginia Medical School, Department of Dermatology, United States

Abstract

The taxanes, docetaxel and paclitaxel, are microtubule stabilizing chemotherapeutic agents that have demonstrated antineoplastic effects in a variety of solid tumors. They have been linked to the development of localized cutaneous sclerosis in some patients. We present a case of docetaxel-induced cutaneous sclerosis of the lower extremities in a patient with pre-existing CREST syndrome. We propose that patients with a history of limited or diffuse systemic sclerosis should be given taxane chemotherapy with caution, as these patients may have an immunological predisposition for the development of drug-induced morphea.

Keywords

CREST syndrome; scleroderma; morphea; docetaxel; taxane

Full Text:

PDF
HTML
Submitted: 2010-06-29 21:32:13
Published: 2010-07-20 08:42:49
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
1204

Views:
PDF
117
HTML
950

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2010 Susan Michele Bouchard, Melinda Mohr, Robert Pariser

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185